Octave Specialty (OSG) EBIT (2010 - 2026)

Octave Specialty's EBIT history runs 17 years deep, the most recent figure standing at $2.4 million for Q1 2026.

• In Q1 2026, EBIT fell 16.34% year-over-year to $2.4 million; the TTM figure through Mar 2026 stood at -$41.5 million (down 404.5% YoY), while the FY2025 annual figure was -$148.2 million, down 1125.8% from the prior year.
• EBIT was $2.4 million for Q1 2026 at Octave Specialty, up from -$49.1 million in the prior quarter.
• In the past five years, EBIT ranged from a high of $11.0 million in Q3 2022 to a low of -$49.1 million in Q4 2025.
• Historically, EBIT has averaged -$326882.4 across 5 years, with a median of $3.5 million in 2024.
• The sharpest annual moves came in 2023 and 2025: EBIT jumped 114.41% in 2023, then plunged 1480.71% in 2025.
• A 5-year view of EBIT shows it stood at $10.5 million in 2022, then slumped by 65.84% to $3.6 million in 2023, then decreased by 0.86% to $3.6 million in 2024, then slumped by 1480.71% to -$49.1 million in 2025, then soared by 104.8% to $2.4 million in 2026.
• The last three EBIT figures came in at $2.4 million (Q1 2026), -$49.1 million (Q4 2025), and $2.7 million (Q3 2025), per Business Quant data.